Literature DB >> 25135836

Repeat analysis and incurred sample reanalysis: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Eric Fluhler1, Faye Vazvaei, Puran Singhal, Petra Vinck, Wenkui Li, Jignesh Bhatt, Theo de Boer, Ajai Chaudhary, Masahiro Tangiuchi, Vinicius Rezende, Dafang Zhong.   

Abstract

The A7 harmonization team (A7 HT), a part of the Global Bioanalysis Consortium (GBC), focused on reviewing best practices for repeat analysis and incurred sample reanalysis (ISR) as applied during regulated bioanalysis. With international representation from Europe, Latin America, North America, and the Asia Pacific region, the team first collated common practices and guidance recommendations and assessed their suitability from both a scientific and logistical perspective. Subsequently, team members developed best practice recommendations and refined them through discussions and presentations with industry experts at scientific meetings. This review summarizes the team findings and best practice recommendations. The few topics where no consensus could be reached are also discussed. The A7 HT recommendations, together with those from the other GBC teams, provide the basis for future international harmonization of regulated bioanalytical practices.

Mesh:

Year:  2014        PMID: 25135836      PMCID: PMC4389737          DOI: 10.1208/s12248-014-9644-1

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  5 in total

1.  Bioanalytical method validation--a revisit with a decade of progress.

Authors:  V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Building the Global Bioanalysis Consortium - working towards a functional globally acceptable and harmonized guideline on bioanalytical method validation.

Authors:  Peter van Amsterdam; Mark Arnold; Surendra Bansal; Douglas Fast; Fabio Garofolo; Steve Lowes; Philip Timmerman; Eric Woolf
Journal:  Bioanalysis       Date:  2010-11       Impact factor: 2.681

3.  Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Authors:  C T Viswanathan; Surendra Bansal; Brian Booth; Anthony J DeStefano; Mark J Rose; Jeffrey Sailstad; Vinod P Shah; Jerome P Skelly; Patrick G Swann; Russell Weiner
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

4.  Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.

Authors:  V P Shah; K K Midha; S Dighe; I J McGilveray; J P Skelly; A Yacobi; T Layloff; C T Viswanathan; C E Cook; R D McDowall
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

Review 5.  Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.

Authors:  Douglas M Fast; Marian Kelley; C T Viswanathan; Jacqueline O'Shaughnessy; S Peter King; Ajai Chaudhary; Russell Weiner; Anthony J DeStefano; Daniel Tang
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

  5 in total
  7 in total

1.  Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.

Authors:  Rong Liu; Brian Hoffpauir; Shannon D Chilewski; Janice Gamberdella; Uma Kavita; Jia Duo; Carol Gleason; Yan Zhang; Renuka Pillutla; Binodh DeSilva; Lora Hamuro
Journal:  AAPS J       Date:  2016-10-27       Impact factor: 4.009

2.  Introduction to the proposals from the global bioanalysis consortium harmonization team.

Authors:  Philip Timmerman; Mark Arnold; Binodh DeSilva; Fabio Garofolo; Michaela Golob; Peter van Amsterdam; Shinobu Kudoh; Puran Singhal; Daniel Tang; Maria Francesca Riccio; Rafael Barrientos; Shrinivas Savale; Tatsuo Kurokawa
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

3.  A sensitive and selective LC-MS/MS method for quantitation of ivermectin in human, mouse and monkey plasma: clinical validation.

Authors:  Yashpal S Chhonker; Liping Ma; Constant Edi; Daryl J Murry
Journal:  Bioanalysis       Date:  2018-10-16       Impact factor: 2.681

4.  Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF-200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials.

Authors:  Ben Novak; Janet DuBois; Osama Chahrour; Tamara Papusha; Stefan Hirt; Thomas Philippi; Corinna Zogel; Katharina Osenberg; Beate Schmitz; Hermann Lübbert
Journal:  Clin Pharmacol Drug Dev       Date:  2021-10-11

5.  Quantification of Colistin in Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study.

Authors:  Kamal M Matar; Batool Al-Refai
Journal:  Sci Rep       Date:  2020-05-18       Impact factor: 4.379

6.  Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.

Authors:  Annick Menetrey; Annick Janin; John Pullman; J Scott Overcash; Amina Haouala; François Leylavergne; Laurent Turbe; Frederick Wittke; Valérie Nicolas-Métral
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

7.  A simple, high-throughput and validated LC-MS/MS method for the determination of azithromycin in human plasma and its application to a clinical pharmacokinetic study.

Authors:  Yuning Zhang; Veenu Bala; Yashpal S Chhonker; Wafaa N Aldhafiri; Lucy N John; Catherine M Bjerum; Christopher L King; Oriol Mitja; Michael Marks; Daryl J Murry
Journal:  Biomed Chromatogr       Date:  2022-07-19       Impact factor: 1.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.